[1] Preaud E,Uhan M, Bohm K, et a1.Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany[J]. Hum Vaccine Immunother.2015,1l(4):884-896.
[2] Gerada, C., Campbell, T. M., Kennedy, J. J., McSharry, B. P., Steain, M., Slobedman, B., & Abendroth, A. (2020). Manipulation of the innate immune response by varicella zoster virus. Frontiers in immunology, 11, 1.
[3] 5 Things You Need to Know About Shingles. National Institute on Aging. Accessed April 7, 2022. https://www.nia.nih.gov/health/infographics/5-things-you-need-know-about-shingles
[4] Lu, L., Suo, L., Li, J., & Pang, X. (2018). A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China. Human Vaccines & Immunotherapeutics, 14(11), 2632-2635.
[5] About Herpes Zoster Shingrix Vaccine: For Providers | CDC. Published February 8, 2022. Accessed April 7, 2022.